APACT: Phase III randomized trial of adjuvant treatment with nab-paclitaxel (nab-P) plus gemcitabine (Gem) versus Gem alone in patients (pts) with resected pancreatic cancer (PC) Meeting Abstract


Authors: Tempero, M. A.; Cardin, D. B.; Goldstein, D.; O'Reilly, E. M.; Philip, P. A.; Riess, H.; Macarulla, T.; Yung, L.; Li, M. Y.; Lu, B. D.; Biankin, A.
Abstract Title: APACT: Phase III randomized trial of adjuvant treatment with nab-paclitaxel (nab-P) plus gemcitabine (Gem) versus Gem alone in patients (pts) with resected pancreatic cancer (PC)
Meeting Title: 2016 Gastrointestinal Cancers Symposium
Journal Title: Journal of Clinical Oncology
Volume: 34
Issue: 4 Suppl.
Meeting Dates: 2016 Jan 21-23
Meeting Location: San Francisco, CA
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2016-02-01
Language: English
ACCESSION: WOS:000378109600455
PROVIDER: wos
DOI: 10.1200/jco.2016.34.4_suppl.tps473
Notes: Meeting Abstract: TPS473 -- Gastrointestinal Cancers Symposium -- JAN 21-23, 2016 -- San Francisco, CA -- S -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Eileen O'Reilly
    780 O'Reilly